Carregant...
Have adjuvant tyrosine kinase inhibitors lost their shine?
Despite broad advances in molecularly targeted therapies, lung cancer remains the leading cause of cancer related mortality in the United States. Epidermal growth factor receptor (EGFR) mutations occur in approximately 17% of advanced non-small cell lung cancer (NSCLC) in the US population. The rema...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980379/ https://ncbi.nlm.nih.gov/pubmed/27568486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.07.18 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|